Conference Call to be held on Tuesday, February 21st, 2023 at Noon ET
EDINBURGH, Scotland, Feb. 13, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced that it now plans to host its shareholder update call on Tuesday, February 21, 2023, at 12:00 p.m. ET. The call was originally scheduled for Monday, February 20, 2023, at 10:00 a.m. ET.
Management intends to provide a comprehensive update on the Company's clinical trial plan for its allogeneic gamma delta therapeutic in oncology indications as well as insight on the company's 2023 outlook and discuss business development efforts. The Company intends to provide a forum for Q&A after opening remarks from senior management.
The Company will answer pre-submitted questions. Investors are asked to submit their questions to IR@tcbiopharm.com
| Conference Call Information: | |
| Date: | Tuesday, February 21, 2023 |
| Time: | 12:00 pm Eastern Time |
| Live Call: | 1-877-704-4453 (U.S. Toll-Free) or 1-201-389-0920 (International) |
| Webcast: | |